2012 Fiscal Year Final Research Report
The establishment of the new treatment strategy according to angiogenetic dependence using a bladder cancer carcinogenic model
| Project/Area Number |
23791789
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Urology
|
|---|
| Research Institution | Keio University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Keywords | 腫瘍学 |
|---|
| Research Abstract |
The cancerogenesis of the bladder cancer was accelerated by ARB(Irbesartan, Telmisartan, Candesartan) in a mouse bladder carcinogenic model using N-butyl-N-(4-hydroxybutyl) nitrosamine. Andcompared to ARB (Candesartan) having no PPAR-γ ac
|
